By Carl O'Donnell
(Reuters) - Owens & Minor Inc is exploring a sale of the company, people familiar with the matter said on Wednesday, as the U.S. medical supplies distributor seeks to recover from a string of disappointing earnings.
The Richmond, Virginia-based company's shares tumbled as much as 20 percent on Wednesday, the day after it reported fourth-quarter earnings that missed analysts' expectations amid fierce price competition in its hospital supplies business.
Owens & Minor, which has a market capitalization of $420 million, is working with investment banks to explore a sale, said the sources, who asked not to be named because the matter is confidential. They cautioned there is no guarantee that the talks will result in a deal.
Owens & Minor did not respond to a request for comment.
The company provides supply chain management to healthcare services vendors and manufacturers of healthcare products, supplies and devices.
Owens & Minor Chairman Robert Sledd told analysts on the company's earnings call earlier on Wednesday that the company experienced a "perfect storm" in 2018, with some issues self-inflicted and others outside its control. These challenges included supply disruptions caused by mergers and acquisitions of manufacturers, and a spate of natural disasters, Sledd said.
The company's goal is to have these service issues behind it by midyear, said Sledd, who was named chairman and interim chief executive in November.
The company on Wednesday also announced a new CEO, Ed Pesicka, the former chief commercial officer of Thermo Fisher Scientific Inc, who will start on March 4.
Last year, Owens & Minor acquired the surgical and infection prevention business of Halyard Health, which has since changed its name to Avanos Medical Inc, for $710 million.
The deal helped it move into new markets, expand its sales team, and build out its portfolio of medical products, but also added substantially to its debt load, which exceeded $1.65 billion as of the end of December.
In 2017, Owens & Minor acquired Byram Healthcare, a medical supply distributor that delivers directly to patients and home health agencies, for around $380 million.
(Reporting by Carl O'Donnell in New York; Editing by David Gregorio and Leslie Adler)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
